Evaluation of anti-CCP antibody for diagnosis of rheumatoid arthritis

Clinical Laboratory

Volumn 57, Issue 11-12, 2011, Pages 895-899

  Afza, Nadeem ^a   Karim, Sara ^a   Mahmud, Tafazzul E Haque ^b   Sami, Waqas ^a   Arif, Maria ^a   Abbas, Sarwar ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b Immunology Sheikh Zayed Hospital   (Pakistan)

Author keywords

Anti keratin antibody; Anti cyclic citrullinated peptide antibody; Anti perinuclear factor; Rheumatoid factor

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; JOINT STIFFNESS; LATEX AGGLUTINATION TEST; MALE; MORNING STIFFNESS; RHEUMATOID ARTHRITIS; SEROLOGY;

ADULT; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; YOUNG ADULT;

EID: 83455244535     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. De Rycke L, Peene I, Hoffman IE, et al. Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestation. Ann Rheum Dis 2004;63:1587-93. (Pubitemid 39573686)
2. Alessandri C, Priori R, Modesti M, Mancini R, Valesini G. The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis. Clinic Rev Allerg Immunol 2008;34:45-9.
3. Klareskog L, Catrina IA, Paget S. Rheumatoid arthritis. The Lancet 2009;373:659-72.
4. th edition, Bone, Joint and Soft Tissue Pathology. 2004;1273-324.
5. De Vries RRP, Huizinga TWJ, Toes REM. Redefining the HLA and RA association: To be or not to be anti-CCP positive. J Autoimm 2005;25:21-5. (Pubitemid 41728039)
6. Panayi SG, Wooley P, Batchelor RJ. Genetic basis of rheumatic disease: HLA antigens, disease manifestations and toxic reactions to drugs. Br Med J 1978;2:1326-28. (Pubitemid 9062106)
7. Weyand MC, Xie C, Goronzy JJ. Homozygosity for HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-39.
8. Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate - a hospital based study. JPMA 2006;56:452-6. (Pubitemid 44904903)
9. Bas S, Perneger TV, Seitz M, Tiercy MJ, Lombard RP, Guerne AP. Diagnostic tests for rheumatoid arthritis. Comparison of anticyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factor. Rheumatol 2002;41:809-14. (Pubitemid 34822965)
10. Vossenaar RE, Venrooij VJ. Anti-CCP antibodies a highly specific marker for early rheumatoid arthritis. Clin Applied Immunol Rev 2004;4:239-62.
11. Khosla P, Shankar S, Duggal L. Anti-CCP antibodies in rheumatoid arthritis. J Indian Rheumatol Assoc 2004;12:143-6.
12. Schellekens GA, Jong BA, van den Hoogen FH, Putte de van LB, Venrooij van JW. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific auto antibodies. J Clin Invest 1998;101:273-81. (Pubitemid 28058927)
13. http://en.wikipedia.org/wiki/Rheumatoid-factor
14. Lutteri L, Malaise M, Chapelle PJ. Comparison of second and third generation.anti-CCP antibody assay for detecting rheumatoid arthritis. Clinica Chimica Acta 2007;386:76-81. (Pubitemid 47417966)
15. Zendman WJ, Venrooij VJW, Pruijin MJ. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatol 2006;45:20-5.
16. Schellekens GA, Visser H, Jong BA, et al. The diagnostic properties of RA antibodies recognizing cyclic citrullinated peptide. Arthritis Rheum 2000;43(1):155-63. (Pubitemid 30368225)
17. Malek Komoun: Diagnostic performances and predictive value of anti-CCP Abs for diagnosis of RA. Clinical Chemistry 2005;51:12-3.
18. J Avouac, L Gossec, M Dougados: Diagnostic and predictive value of anti-CCP protein antibodies in rheumatoid arthritis. Ann Rheum Dis 2006;65:845-51.
19. Quinn AM, Gough SA, Green JM, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatol 2005;45:478-80.
20. Nielen MJ, Schaardenburg VD, Reesink WH. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 2004; 380-6.
21. Vallbracht I, Helmke K. Additional diagnostic and clinical value of anti-CCP antibodies compared with RF Isotypes in RA. Autoimmunity Reviews 2005;4:389-94.
22. Brunner J, Sitzmann FC. The diagnostic value of anti-CCP antibodies in children with Juvenile Idiopathic Arthritis. Clin Exp Rheumatol 2006;24(4):449-51. (Pubitemid 44363549)
23. Lipinska J, Smolewska E, Brozik H, Stanczyk J. Anti-CCP antibodies in children with juvenile idiopathic arthritis diagnostic and clinical significance. Centr Eur J Immunol 2008;33(1):19-23. (Pubitemid 351578996)
24. Mediwake R, Isenberg AD, Schellekens GA, Venrooj VW. Use of anti-citrullinated peptide and anti-RA33 Abs in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2001;60:67-8. (Pubitemid 32038957)
25. Gottenberg JE, Mignot S, Rolland NP, et al. Prevalence of anti-CCP and anti-Keratin antibodies in patients with primary Sjogern's syndrome. Ann Rheum Dis 2005;64:114-7. (Pubitemid 40075286)
26. Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M. Diagnostic value of antibodies against modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 2006;8(4):119 1-6.
27. Kastbom A, Strandberg G, Lindroos A, Skogh T. Anti-CCP antibody test predicts the disease course during three years in early rheumatoid arthritis. Ann Rheum Dis 2004; 63:1085-9. (Pubitemid 39120359)
28. Bizaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy of anti-citruuline antibody assay for rheumatoid arthritis. Clinical Chemistry 2001;1089-93. (Pubitemid 32493596)
29. De Rycke L, Peene I, Hoffman IE, et al. Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestation. Ann Rheum Dis 2004;63:1587-93. (Pubitemid 39573686)
30. http://www.rheumatology.org/practice/clinical/classification/ra/ra.asp
31. Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 2004;31:1723-6. (Pubitemid 39202511)